Arda Therapeutics

Arda’s stated goal is to take aim at chronic diseases and aging by eliminating the pathological cells that drive these conditions. The company intends to use single-cell data in order to identify which pathological cells to target, discover how to target them, and design therapies to eliminate those specific cells. Arda Therapeutics is backed by well-known venture capital funds, including Andreessen Horowitz and The Longevity Fund.